Under the provisions of article 10 par. 1 of L. 3340/2005 and article 2 of Board’s Decision 3/347/12-07-2005 of Hellenic Capital Market Commission, ELGEKA S.A. informs the investing public and its shareholders that today, 21/07/2011, paid the sum of EUR 710,000 in order to participate in the increase of the share capital of its subsidiary "MEDIHELM PHARMAC.WHOLESALE STORE S.A.".

In particular, the Annual General Meeting of the company "MEDIHELM PHARMAC.WHOLESALE STORE S.A." decided on 30/06/2011 to increase its share capital by EUR 710,000 by issuing 71,000 new common shares, at a nominal value of EUR 10 each. Consequently, its new share capital will amount to a total of EUR 3,070,000 divided into 307,000 common shares with a nominal value of EUR 10 each.

After the explicit and unreserved statement of the other shareholder that it will not participate in the above mentioned share capital increase of "MEDIHELM PHARMAC.WHOLESALE STORE S.A.", ELGEKA S.A. undertook to cover entirely this increase and therefore its participation percentage in the above company increased from 98.48% to 98.83% approximately.

Thessaloniki, 21^st of July 2011